Toshiba Medical Systems Corporation
Business Outline
Sep, 2015
Disclaimer: Caution Concerning Forward-Looking Statements
This document contains projections of business results, statements regarding business
plans and other forward-looking statements. This information is based on certain
assumptions, such as the economic environment, business policies and other factors.
Actual results may differ significantly from the estimates listed here.
2
Toshiba’s Vision
Our Aim: Providing Products + Excellent User Experiences
3
Business Field of TMSC in the Healthcare Cycle
②
Screening
①
③
Diagnosis
Healthcare Cycle
⑥
Home-care/
Monitoring
Diagnosis to Treatment
⑤
Management/
Rehabilitation
Medical Information
Networking/Solution
Screening to Diagnosis
Prediction
④
Treatment
Targeting Broader Care Phases (Screening–Diagnosis–Treatment) for
1) Early Detection, 2) Diagnostic Accuracy / Efficiency and
3) Less-invasive Treatment
4
Toshiba Group Structure
Board of Directors
President & CEO
Corporate Staff
Corporate R&D Center
Corporate Software
Engineering Center
Corporate
Manufacturing
Engineering Center
Cloud & Solutions
Company
Energy & Infrastructure
Group
Electronic Devices &
Components Group
Healthcare Systems &
Services Group
Toshiba Medical Systems Co.
Lifestyle Products & Services
Group
Community Solutions Group
5
TMSC Contribution in Toshiba Group
Toshiba Gr. Net Sales FY14 USD 67B
(USD=JPY100)
Energy & Infrastructure
28%
Others
Lifestyle
7%
19%
16%
24%
Community Solutions
6%
Healthcare
USD4.1B (JPY 413B)
Electronic Devices
6
Corporate Profile
Company name :
Business Start
: 1914
Foundation
: 1930
President & CEO : Toshio Takiguchi
Headquarters
: Tochigi, JAPAN
Site Area
：354,900㎡
Capital
: 20.7 billion yen
Revenue
: 405billion yen (4 billion US$)
TMSC HQ
(TMSC Consolidated FY14)
Global Employees: 9,760 (As of Mar. 2015)
Toshio Takiguchi
7/17
Location of TMSC HQ
Shiobara
Nikko
Otawara
150km (90 miles)
from Tokyo
Utsunomiya
Mashiko
Narita
Tokyo
8
Corporate History
1875
Tanaka Manufacturing founded
1985
World’s First
Slip ring CT
scanner
1914
Research & Development of
Japan’s first X-ray tube
1915
Japan’s First
X-ray tube
1930
Japan Medical
Electronics
2015
2003
Toshiba Medical Systems Co.
1938
Japan’s First
Japan’s
First
Tomography
System
© 2015 Toshiba Corporation
9
Main Products
Imaging Solutions
PET-CT
Systems
Nuclear Medicine
Systems (Japan)
Radiation Therapy
Systems (Japan)
CT Systems
Vascular Systems
Workstation
X-ray Systems
Hospital Information
System
Clinical Laboratory
Systems
Ultrasound
Systems
Image Network
Solution
Information System
for Clinics
MRI Systems
(Electronic Medical
Record/Ordering)
(Electronic Medical Record/
Medical Business Accounting)
Medical Information Solutions
10
FY2014 TMSC Group Consolidated Revenue
FY2014 USD 4.1 B
Business Segment
Others
Area (Main Business)
Japan
CT
33%
39%
8% MRI
Overseas
UL
14%
67%
XR
16%
11
Worldwide Sales & Service Network
Through 11 subsidiaries and 77 distributors,
We provide sales & service of medical equipment
in more than 135 countries around the world
Toshiba Medical
Systems Europe B.V.
Founded
in 1981
Toshiba Medical
Systems Turkey
Founded
in 2013
Toshiba of
Canada Ltd.
Toshiba Medical
Systems China, Inc.
Vital Images, Inc.
Founded in 2007
Toshiba Medical
Systems Korea, Inc.
Founded
in 2013
Toshiba Medical Systems
Malaysia Sdn. Bhd.
Founded
in 2014
Medical Div.
founded in 1986
Acquired in 2011
Toshiba Medical
Systems Corporation
Toshiba America
Medical Systems, Inc.
Medical Div.
Founded in 1976
Toshiba Medical
Systems Asia Pte, Ltd.
Founded in 1995
Toshiba (Australia)
Pty., Ltd.
Toshiba Medical
do Brasil, Ltda
Founded in 1974
Medical Div. founded in 1980
© 2015 Toshiba Corporation
12
Our Management Slogan
© 2015 Toshiba Corporation
13
New Solutions Concept Based on Clinical Needs
Assisting in
Hospital Management
Improving
Workflow
Providing
Clinical Value
© 2015 Toshiba Corporation
14
Global R&D
Global R&D network for products, services and technologies that contribute to the
improvement of clinical values and medical efficiencies through collaboration with
leading academic institutions.
Established in 2008
(TMVS)
Toshiba Medical Visualization
Systems Europe, Ltd.
Toshiba Software India Pvt. Ltd.
Established in 2012
(TMC)
Software Development
Center
(TMSC)
Established in 2013
(TMRD)
Established in 2006
(TMRU)
Vital Images, Inc.
Toshiba Medical Research
Institute USA, Inc.
Healthcare Technology Center
Established in Dec 2014
Toshiba Medical Systems
R&D (Dalian) Co., Ltd.
Toshiba Medical Systems
Corporation
Nasu Headquarters
Acquired in 2011
・ Combination of wide-ranging
technology asses of the Toshiba Group
・ Acceleration of Development
for next-generation products
・ Research and development
of differentiating technologies
on mid- and long-term basis
Corporate
Corporate
Software
Manufacturing
Engineering Center Engineering Center
© 2014 Toshiba Corporation
15
Global Manufacturing & Procurement
Global production system to support continuous sales growth and profit maximization
Management of local production requirements in various regions
Established in 2012
Established in 1991. Started manufacturing of medical systems in 2002
Role of base
TMSC
Dalian,
China
Chinese Procurement
Center
(TDL)
Toshiba Dalian Ltd.
Malaysia
Brazil
Manufacturing
Mother factory
Manufacturing base for lowend models and units
Manufacturing base for
ultrasound systems and PWBs
Manufacturing base for
expansion of sales
(TMSC)
Toshiba Medical Systems
Corporation
Nasu Headquarters
(TMMA) Started operation in Dec 2014
Toshiba Medical Systems Manufacturing Asia SDN. BHD.
(TMB) Started operation in Jan 2013
Toshiba Medical do Brasil Ltda.
© 2014 Toshiba Corporation
16
360 Degree Safety
 Dose reduction/
management
 Ensuring patient safety
 Ensuring safe environment
for operators
 Reduction of operational
errors
 Provision of safety
education/service
Toshiba ensures
safety for
patients and all
people involved
in healthcare.
Non-contrast MRA
Workstation
CT
MR
UL
XR
© 2015 Toshiba Corporation
17
Toshiba’s Low Dose Technique:
Standard feature on all CT models
We aim to reduce CT dose by 50%
series
series
series
＊AIDR 3D=Adaptive Iterative Dose Reduction 3D
18
Dose Management
Dose management with integrated exposure dose reduction for patients and
medical staff
SpotFluoro function
X-rays are transmitted only to the
target region, reducing exposure
dose for the patient by up to
90% and for the operator by up
to 70%.
Dose Tracking System
Visualization of exposure dose
Realtime monitoring of skin
exposure during procedure
Exposure area
outside the target
region (not necessary)
Target region during
catheter operation
© 2015 Toshiba Corporation
19
Advanced Medical Technology for the Diagnostic Imaging Field
Worldwide clinical study using the latest CT (Aquilion ONE)
Participation of 16 organizations in 8 countries
Conventional Method
Coronary artery
angiography
Myocardial SPECT
Uses catheters
& radioactive
chemicals
Canada
Europe
USA
Japan
Singapore
Cardiac test using Aquilion ONE
Coronary artery
CT angiography
Myocardial CT
perfusion
Brazil
Single CT
imaging
・Reduced radiation
USA
・Reduced dosage
★Johns Hopkins University
of contrast medium Harvard University-affiliated
・Shortened exam time hospitals
Beth Israel Deaconess
Medical Center
Brigham and Women's
Hospital
National Institute of Health
Japan
Europe
Iwate Medical University
Mie University
Keio University
St Luke’s International
Hospital
University Clinic Humboldt
University(Charité,)
Leiden University Medical
Center
Copenhagen University
Hospital (Rigshospitalet)
Singapore
Mount Elizabeth Hospital
National Heart Center
Canada
University of Toronto
Toronto General Hospital
★Main PI (Principal Investigator)
Brazil
University of São Paulo
(INCOR)
Albert Einstein Israelite
Hospital
20
Non-contrast MRI Multicenter Study
The results of the international multicenter trial “REACT” (REnal Artery Contrast-free Trial)
were published in
as clinical evidence.
AJR
American Journal of Roentgenology
2015-January
edition
Non-contrast imaging technology Time-SLIP
(Time-Spatial Labeling Inversion Pulse) was
compared with CT angiography in terms of ability
to diagnose renal artery stenosis, and its clinical
usefulness was verified.
The value of the Time-SLIP method as a safe
alternative evaluation method to CTA (which
requires use of contrast medium) was verified.
Global doctors
collaborating on
REACT
Advanced Diagnostic
Imaging Center,
Monterey, CA, USA
Bois de Verrières
Medical Imaging Center,
Antony, France
Centros Médicos Creu
Blanca, Barcelona, Spain
Fundació Puigvert,
Barcelona, Spain
Renal artery non-contrast image
acquired using a Toshiba MRI
system.
Peking Union
Medical College
Hospital,
Beijing, China
University of Tokyo,
Tokyo, JAPAN
University of Texas
Health Science
Center, San
Antonio, TX, USA
© 2015 Toshiba Corporation
21
Social Contribution Through Provision of
Environmentally Friendly Products
Establishment of eco-company brand in the medical equipment market
Green Processes
Energy conservation/resource
conservation/elimination of hazardous
substances throughout processes, from
procurement to servicing
Green Products
Development of
environmentally friendly
products
Small installation space
(min. 23 m2）
Quick installation (as short as 5
days）
Reduced power consumption
(30% reduction)
Transformation of green space within the
grounds of headquarters
We are promoting creation of an environment which is
friendly to flora and fauna
Size reduction (48% lower product
weight）
Reduced power consumption (14%
reduction)
22
23
From Start-up to Global R&D Center of
Excellence
Ken Sutherland
President - TMVS
Company Timeline
1999
Started working
with Toshiba
2001
st
1 Ultrasound
product
for Toshiba
2003
1st Technology
Framework R&D
for Toshiba
2009
Acquired
by Toshiba
1994
Company
Start-up
Toshiba
Corporate
Energy
Data
Healthcare
Medical
TMVS
Acquisition and Investment
New Talent Acquisition
SUPA Inspire Studentship
with Toshiba Medical
Visualization Systems
Taking Scottish Innovation to a Global Market
Toshiba, EDINBURGH
3. GLOBAL SALES
& MARKETING
1. CREATIVE
INNOVATION
Toshiba Medical Systems, JAPAN
2. PRODUCT INTEGRATION
& TESTING